英文别名:
1-Naphthalenamine, 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, (1R,4S)-;(1R,4S)-Sertraline HCl;rac-trans-Sertraline;79951-46-5;trans-(+/-)-sertraline;1-Naphthalenamine, 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, (1R,4S)-rel-;(1R,4S)-4-(3,4-Dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthalenamine;PD062159;SCHEMBL3947169;BRD-K70464547-003-01-2;CP50723;UNII-4N6S45X78A;C90546;1-Naphthalenamine, 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, trans-(+/-)-;Sertraline, (1RS,4SR)-;79836-45-6;BDBM82217;1-Naphthalenamine, 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, (1R-trans)-;ZUY6SFU8RX;VGKDLMBJGBXTGI-YVEFUNNKSA-N;Sertraline, trans-(+/-)-;Sertraline hydrochloride specified impurity A [EP];Q27260225;4N6S45X78A;107508-17-8;DTXSID50904948;CP-52003;Racemic trans-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl- 1-napthalenamine;(1RS,4SR)-4-(3,4-Dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine;CP-50723;Sertraline, (1R,4S)-;[4-(3,4-Dichloro-phenyl)-1,2,3,4-tetrahydro-naphthalen-1-yl]-methyl-amine;(1R,4S)-4-(3,4-DICHLOROPHENYL)-N-METHYL-1,2,3,4-TETRAHYDRONAPHTHALEN-1-AMINE;(1R,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine;SERTRALINE HYDROCHLORIDE IMPURITY A [EP IMPURITY];(1R,4S)-Trans-Sertraline;Sertraline (1R,4S)-Isomer;AKOS030242812;CHEMBL284994;
Inchi:
1S/C17H17Cl2N.ClH/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11;/h2-6,8,10,12,17,20H,7,9H2,1H3;1H/t12-,17-;/m0./s1